- Home
- KOS vs QDEL Comparison
KOS vs QDEL Comparison
Compare KOS & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KOS | QDEL |
|---|---|---|
| Founded | 2003 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2011 | 2022 |
Fundamental Metrics
Financial Performance| Metric | KOS | QDEL |
|---|---|---|
| Price | $2.68 | $16.94 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $1.76 | ★ $32.75 |
| AVG Volume (30 Days) | ★ 31.3M | 1.2M |
| Earning Date | 03-02-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | $1,288,352,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $21.14 | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.84 | $15.08 |
| 52 Week High | $3.01 | $37.24 |
Technical Indicators
Market Signals| Indicator | KOS | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 60.74 | 34.67 |
| Support Level | $1.53 | N/A |
| Resistance Level | $2.77 | $30.65 |
| Average True Range (ATR) | 0.23 | 1.17 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 69.27 | 25.69 |
Price Performance
Historical ComparisonAbout KOS Kosmos Energy Ltd. (DE)
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.